FY2026
Effective from
- Inherited rules changed
Encounter for screening for malignant neoplasm of cervix
Billable diagnosis code
CDC/NCHS · FY2026when screening is part of general gynecological examination (Z01.4-)
code to identify any family history of malignant neoplasm (Z80.-)
encounter for diagnostic examination-code to sign or symptom
encounter for screening for human papillomavirus (Z11.51)
Coverage depends on the payer, service and applicable policy. A billable code does not guarantee payment.
For US diagnosis claims covered by HIPAA, ICD-10-CM is required from October 1, 2015.
Use the service date for outpatient/professional claims and the discharge date for hospital inpatient claims. Earlier encounters use ICD-9-CM; each individual code must also be valid for the applicable date.
Official coding guidelines → · CMS ↗Grouping depends on the complete encounter and CMS grouper logic.
2026-04-01 – 2026-09-30
CMS · MS-DRG 43.1First observed · 2015-10-01
Latest recorded change · FY2026
Effective from
Encounter for screening for malignant neoplasm of cervix
Billable diagnosis code
CDC/NCHS · FY2026| All editions | Effective from | Code history |
|---|---|---|
| FY2016 | 2015-10-01 | First observed |
| FY2017 | 2016-10-01 | Code-level rules changed |
| FY2018 | 2017-10-01 | No tabular change |
| FY2019 | 2018-10-01 | No tabular change |
| FY2020 | 2019-10-01 | No tabular change |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | No tabular change |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | No tabular change |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | No tabular change |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | Inherited rules changed |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
Historical mapping only; not an automatic code substitution.
Encounter for screening pap smear for malignant neoplasm of cervix
when screening is part of general gynecological examination (Z01.4-)
encounter for screening for human papillomavirus (Z11.51)
Screening is the testing for disease or disease precursors in asymptomatic individuals so that early detection and treatment can be provided for those who test positive for the disease.
encounter for diagnostic examination-code to sign or symptom
code to identify any family history of malignant neoplasm (Z80.-)
Other entries in the same category; these are not automatic substitutes.
| Code | Description | Category · further specificity required |
|---|---|---|
| Z12.0 | Encounter for screening for malignant neoplasm of stomach | Billable / specific |
| Z12.1 | Encounter for screening for malignant neoplasm of intestinal tract | Category · further specificity required |
| Z12.2 | Encounter for screening for malignant neoplasm of respiratory organs | Billable / specific |
| Z12.3 | Encounter for screening for malignant neoplasm of breast | Category · further specificity required |
| Z12.5 | Encounter for screening for malignant neoplasm of prostate | Billable / specific |
| Z12.6 | Encounter for screening for malignant neoplasm of bladder | Billable / specific |
| Z12.7 | Encounter for screening for malignant neoplasm of other genitourinary organs | Category · further specificity required |
| Z12.8 | Encounter for screening for malignant neoplasm of other sites | Category · further specificity required |
| Z12.9 | Encounter for screening for malignant neoplasm, site unspecified | Billable / specific |
Official titles and instructions are preserved in their source language. Official sources ↗